Vimarsana
Biggest News Aggregation in the World

Chris Ren News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chris Ren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chris Ren Today - Breaking & Trending Today

ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcript - Vimarsana News

ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcript

Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences second quarter 2023 earnings call.

Three High School Students Use Generative AI to Discover New Brain Tumor Drug Targets - Vimarsana News

Three High School Students Use Generative AI to Discover New Brain Tumor Drug Targets

Three high school students – Andrea Olsen from Oslo, Norway; Zachary Harpaz from Boca Raton, Florida; and Chris Ren from Shanghai, China – co-authored a paper using a generative artificial intelligence (AI) engine for target discovery from Insilico Medicine (“Insilico”) called PandaOmics to identify new therapeutic targets for glioblastoma multiforme (GBM).

Targets Implicated in Aging and Glioblastoma Multiforme Using PandaOmics - Vimarsana News

Targets Implicated in Aging and Glioblastoma Multiforme Using PandaOmics

Andrea Olsen from Oslo, Norway; Zachary Harpaz from Boca Raton, Florida; and Chris Ren from Shanghai, China, are three high school students who co-authored a paper utilizing a generative artificial intelligence (AI) engine for target discovery from Insilico Medicine (“Insilico”) known as PandaOmics.

High school student researchers find new brai - Vimarsana News

High school student researchers find new brai

Three high school students – Andrea Olsen from Oslo, Norway; Zachary Harpaz from Boca Raton, Florida; and Chris Ren from Shanghai, China – co-authored a paper using a generative artificial intelligence (AI) engine for target discovery from Insilico Medicine called PandaOmics to identify new therapeutic targets for glioblastoma multiforme. The findings were published on April 26 in the journal Aging.